Clinical Trial Update: Study of AMXT 1501 and DFMO in Combination With Standard Therapies in Advanced Solid Tumors [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 clinical trial evaluating the combination of AMXT 1501 and DFMO with standard therapies in patients with advanced solid tumors, including Melanoma a…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer
• Melanoma

Drugs mentioned

• AMXT 1501 (AMXT-1501)
• DFMO (difluoromethylornithine)

Snippet

Sponsor: Aminex Therapeutics, Inc. | Conditions: Melanoma (Skin Cancer), HER2-low Hormone Receptor Positive Breast Cancer | Phase 1, Phase 2 | Status: RECRUITING